The Lebanon Healthcare Journal
SEE OTHER BRANDS

Fresh health and wellness news from Lebanon

The Lebanon Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Lebanon Healthcare Journal.

Press releases published on June 10, 2025

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO™ Sacroiliac (SI) Joint …

Kraig Biocraft Laboratories Announces Senior Management Trip to Southeast Asia to Oversee Expansion of Spider Silk Production

Kraig Biocraft Laboratories Announces Senior Management Trip to Southeast Asia to Oversee Expansion of Spider Silk Production

ANN ARBOR, Mich., June 10, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that senior management will travel to Southeast Asia this week to oversee …

NHS Management Turns to Vetty and Chattr to Supercharge Health Care Staffing

NHS Management Turns to Vetty and Chattr to Supercharge Health Care Staffing

AUSTIN, Texas and TAMPA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop hiring acceleration platform, and Chattr, automated AI hiring software for the frontline, today shared details of its combined support for NHS Management, LLC, which …

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard) MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage …

Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity

Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity

WEST VALLEY CITY, Utah, June 10, 2025 (GLOBE NEWSWIRE) -- Nusano today announced it has successfully enriched gadolinium-160 (Gd-160) to 99.2% purity, a significant milestone demonstrating the company’s in-house stable isotope production program. “ …

Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters

Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters

Global Superseed Leader, Manitoba Harvest, Expands their Wellness Lineup with Smoothie Blends for Enhanced Nutrition Plus Energy, Mood and Immune Support NEW YORK and WINNIPEG, Manitoba, June 10, 2025 (GLOBE NEWSWIRE) -- Manitoba Harvest, the global leader …

Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China

Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …

e Sono and POCUS Certification Academy Launch Ultrasound Proficiency On-Demand Bundles for Key Clinical and Specialty Certifications

e Sono and POCUS Certification Academy Launch Ultrasound Proficiency On-Demand Bundles for Key Clinical and Specialty Certifications

HAMBURG, Germany and ROCKVILLE, Md., June 10, 2025 (GLOBE NEWSWIRE) -- e Sono (by 3B Scientific), a globally recognized leader in clinical ultrasound simulation, and the POCUS Certification Academy, a globally trusted provider of point-of-care ultrasound ( …

Pharvaris Announces Annual Meeting of Shareholders

Pharvaris Announces Annual Meeting of Shareholders

ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …

Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations

Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Apothecare, Canada’s leading pharmacist-led cannabis consultation service, has partnered with FIKA Cannabis, one of the country’s fastest-growing lifestyle cannabis retailers, to launch professional cannabis …

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized clinical trial designed to demonstrate …

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, …

मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि

मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि

बेंगलुरु, भारत, June 10, 2025 (GLOBE NEWSWIRE) -- बेंगलुरु स्थित बायोटेक्नोलॉजी कंपनी RenaissThera प्राइवेट लिमिटेड ने अपने मोटापा रोधी दवा कार्यक्रम के तहत ग्लूकोज़-डिपेंडेंट इंस्युलिनोट्रॉपिक पोलिपेप्टाइड रिसेप्टर (GIPR) को लक्ष्य करते हुए एक महत्वपूर्ण …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service